If the term "EVPLL" were to reference a specific protein or enzyme that has been characterized and studied, activators of such a protein would represent a class of molecules specifically designed or identified to increase the activity of EVPLL. Assuming EVPLL were an enzyme, the activators would likely be small molecules or perhaps peptides that bind to the enzyme in a manner that enhances its catalytic action. This could occur through direct interaction with the catalytic site of the enzyme, stabilizing the transition state of the reaction it catalyzes, or by binding to an allosteric site, thereby inducing a conformational change that results in increased enzymatic activity.
If we were to imagine a research framework for studying EVPLL Activators, it would involve a series of methodical steps. Initially, researchers would need to establish assays to detect and quantify the activity of EVPLL. Depending on the nature of EVPLL's enzymatic activity, these could include colorimetric assays to measure product formation, fluorescence-based assays if the enzyme's substrates or products were fluorescent, or even radiometric assays using labeled substrates. Once functional assays are established, high-throughput screening could be employed to identify potential activator compounds from large chemical libraries. Following the identification of initial hits, these compounds would undergo optimization to improve their efficacy, selectivity, and potential interaction with EVPLL. Concurrently, detailed mechanistic studies would be carried out to understand how these activators influence EVPLL. This might involve kinetic analysis to determine the impact on the enzyme's V_max (maximum velocity) and K_m (Michaelis constant), indicating changes in catalytic efficiency and substrate affinity. Structural biologists would aim to solve the structure of the enzyme in complex with its activators using techniques such as X-ray crystallography or cryo-electron microscopy, providing detailed insight into the molecular interactions at play. This information could then be used to refine the activator molecules further, leading to a deeper understanding of their mode of action at the molecular level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
Vitamin D3, through its active metabolite, can promote keratinocyte differentiation and potentially induce envoplakin expression. | ||||||
Calcium chloride anhydrous | 10043-52-4 | sc-207392 sc-207392A | 100 g 500 g | $65.00 $262.00 | 1 | |
Calcium ions are known to be critical in keratinocyte differentiation and may enhance the expression of differentiation markers like envoplakin. | ||||||
Vitamin A | 68-26-8 | sc-280187 sc-280187A | 1 g 10 g | $377.00 $2602.00 | ||
Retinol affects skin cell proliferation and differentiation and could upregulate proteins involved in epidermal barrier function. | ||||||
Tazarotene | 118292-40-3 | sc-220193 | 10 mg | $103.00 | ||
A synthetic retinoid that modulates gene expression and keratinocyte differentiation, potentially increasing envoplakin levels. | ||||||
Glycolic acid solution | 79-14-1 | sc-215102 sc-215102A | 25 g 500 g | $38.00 $60.00 | ||
As an alpha-hydroxy acid, glycolic acid can alter epidermal turnover and differentiation, possibly affecting envoplakin expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC) and could induce differentiation in keratinocytes, potentially upregulating envoplakin. | ||||||
C-8 Ceramide | 74713-59-0 | sc-205233 sc-205233A sc-205233B | 1 mg 5 mg 25 mg | $19.00 $63.00 $228.00 | 1 | |
Ceramides are lipid molecules that are central to barrier function and could stimulate the expression of proteins like envoplakin. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $36.00 $102.00 $569.00 $1173.00 | 10 | |
Oleic Acid can disrupt skin barrier function, potentially triggering compensatory mechanisms that include envoplakin expression. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $43.00 $65.00 $200.00 $815.00 | 6 | |
Niacinamide, a form of vitamin B3, can influence skin barrier function and may modulate protein expression in the epidermis. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG has antioxidant properties and may influence cellular protective mechanisms, potentially affecting envoplakin expression. | ||||||